U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
164701164701A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of MalignanciesCompletedNo Results AvailableHematologic MalignanciesProcedure: extracorporeal photopheresis|Drug: Pentostatin|Radiation: Total Body Irradiation|Drug: Pentostatin|Radiation: Total Body Irradiationhttps://ClinicalTrials.gov/show/NCT00402714
164702164702Pedestrian Behavior Following Implementation of a Walking School BusCompletedNo Results AvailableObesityBehavioral: Walking School Bus Programhttps://ClinicalTrials.gov/show/NCT00402701
164703164703An Effectiveness and Safety Study for Levofloxacin in Chronic ProstatitisCompletedHas ResultsProstatitisDrug: levofloxacin|Drug: levofloxacin|Drug: levofloxacinhttps://ClinicalTrials.gov/show/NCT00402688
164704164704Randomized Trial of Immediate Versus Early and Selective Invasive Percutaneous Coronary Intervention in NSTEMICompletedNo Results AvailableMyocardial InfarctionProcedure: Timing of percutaneous coronary interventionhttps://ClinicalTrials.gov/show/NCT00402675
164705164705A Study of Everolimus in Combination With Imatinib in Metastatic MelanomaTerminatedNo Results AvailableMetastatic MelanomaDrug: everolimus|Drug: Imatinibhttps://ClinicalTrials.gov/show/NCT00402662
164706164706Open-Label Study of H5 Vaccine in Participants of Protocol 04-077CompletedHas ResultsInfluenzaBiological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)https://ClinicalTrials.gov/show/NCT00402649
164707164707Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)CompletedNo Results AvailableCoronary Heart DiseaseDevice: rapamycin plus 17beta estradiolvalerat-eluting stent|Device: rapamycin-eluting stenthttps://ClinicalTrials.gov/show/NCT00402636
164708164708The Effect of Quercetin in SarcoidosisCompletedNo Results AvailableSarcoidosisDietary Supplement: quercetin|Other: placebohttps://ClinicalTrials.gov/show/NCT00402623
164709164709A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With AnergyCompletedNo Results AvailableHIV Infections|TuberculosisDrug: isoniazid, rifampin + isoniazid, rifampin + pyrazinamide or not treatmenthttps://ClinicalTrials.gov/show/NCT00402610
164710164710Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)CompletedHas ResultsAcute Coronary SyndromeDrug: Rivaroxaban/Placebo|Drug: Placebo|Drug: Rivaroxabanhttps://ClinicalTrials.gov/show/NCT00402597
164711164711A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating DisorderCompletedNo Results AvailableBinge Eating Disorder|ObesityDrug: sibutraminehttps://ClinicalTrials.gov/show/NCT00402584
164712164712Hepatic Function During and Following Three Days of Acetaminophen Dosing in AlcoholicsCompletedNo Results AvailableAlcohol Related DisordersDrug: acetaminophenhttps://ClinicalTrials.gov/show/NCT00402571
164713164713Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNo Results AvailableMyelodysplastic Syndrome|LeukemiaDrug: Thymoglobulin|Drug: Busulfan|Drug: Fludarabine|Procedure: Alloreactive NK Infusion|Drug: G-CSF|Drug: Tacrolimus|Drug: Methotrexate|Drug: Interleukin-2https://ClinicalTrials.gov/show/NCT00402558
164714164714C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNo Results AvailableHead and Neck NeoplasmsDrug: Cetuximab|Drug: Docetaxel|Drug: Cisplatin|Drug: 5-Fluorouracilhttps://ClinicalTrials.gov/show/NCT00402545
164715164715Immunosuppressive Therapy With Certican (Everolimus) After Lung TransplantationCompletedNo Results AvailableLung TransplantationDrug: Everolimus|Drug: Mycophenolatmofetilhttps://ClinicalTrials.gov/show/NCT00402532
164716164716APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast CancerActive, not recruitingNo Results AvailableBreast CancerRadiation: Accelerated partial breast irradiation|Radiation: External beam whole breast irradiationhttps://ClinicalTrials.gov/show/NCT00402519
164717164717A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABGCompletedNo Results AvailableCoronary Artery Bypass Graft Surgery|Myocardial Ischemia|Reperfusion InjuryDrug: (MC-1) Pyridoxal 5'-phosphatehttps://ClinicalTrials.gov/show/NCT00402506
164718164718Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma DropsCompletedNo Results AvailableGlaucoma|Ocular HypertensionDrug: ibuprofen, latanoprost, brimonidine|Drug: Ibuprofen, brimonidine, latanoprost|Drug: Ibuprofenhttps://ClinicalTrials.gov/show/NCT00402493
164719164719Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow VelocityCompletedNo Results AvailableStrokeDrug: Hydroxyureahttps://ClinicalTrials.gov/show/NCT00402480
164720164720An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging StudyCompletedNo Results AvailableVenous ThromboembolismDrug: Rivaroxaban (BAY59-7939)|Drug: Rivaroxaban, (BAY59-7939)|Drug: Rivaroxaban, (BAY59-7939)|Drug: Rivaroxaban, (BAY59-7939)|Drug: Enoxaparine|Drug: Enoxaparinehttps://ClinicalTrials.gov/show/NCT00402467
164721164721Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium TuberculosisCompletedNo Results AvailableHIV InfectionsDrug: isoniazid, rifampin + isoniazid or rifampin + pyrazinamidehttps://ClinicalTrials.gov/show/NCT00402454
164722164722Risedronate in the Prevention of Osteoporosis in Postmenopausal WomenCompletedNo Results AvailableOsteoporosis, PostmenopausalDrug: Risedronate (HMR4003)https://ClinicalTrials.gov/show/NCT00402441
164723164723Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive PatientsCompletedNo Results AvailableChronic Hepatitis CDrug: albumin interferon alfa-2b|Drug: peginterferon alfa-2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00402428
164724164724Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard TherapyTerminatedNo Results AvailableTumorsDrug: Sunitinib malate|Drug: Rapamycinhttps://ClinicalTrials.gov/show/NCT00402415
164725164725Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver DiseaseCompletedNo Results AvailableChronic Liver Disease|Liver Transplantation|TuberculosisProcedure: Tuberculin skin test|Procedure: Quantiferon-TB Gold assayhttps://ClinicalTrials.gov/show/NCT00402402
164726164726Use of Omega-3 Fatty Acids for Perinatal DepressionCompletedNo Results AvailableDepression|Depression, PostpartumDrug: Omega-3 Fatty Acids (EPA plus DHA)|Behavioral: Supportive psychotherapy|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00402389
164727164727Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological TherapyTerminatedNo Results AvailableHeart FailureDrug: Pravastatin, Carvedilol, Perindopril|Device: Biventricular assist device (Thoratec paracorporeal assist device)https://ClinicalTrials.gov/show/NCT00402376
164728164728Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial FibrillationCompletedHas ResultsFibrillation, Atrial|Atrial FibrillationDrug: omega-3-acid ethyl esters|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00402363
164729164729Staccato® Fentanyl Pharmacokinetics in Healthy VolunteersCompletedNo Results AvailableBreakthrough PainDrug: Staccato Fentanyl|Drug: Staccato Fentanyl|Drug: Staccato Fentanyl|Drug: Staccato Fentanyl|Drug: Staccato Fentanyl|Drug: Staccato placebohttps://ClinicalTrials.gov/show/NCT00402350
164730164730Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic ConstipationCompletedHas ResultsChronic ConstipationDrug: linaclotide acetate|Drug: Matching placebohttps://ClinicalTrials.gov/show/NCT00402337

* Görseller ve İçerik tekif hakkına sahip olabilir